DEANA MCRAE — Lobbyist Profile | Poliscope

DEANA MCRAE

Filings

Clients

Firms

Years active

2020–2026

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
JOHNSON & JOHNSON SERVICES INC	22	2020–2026

Lobbying firms

Firm	Filings	Years
JOHNSON & JOHNSON SERVICES, INC.	22	2020–2026

Bills explicitly cited in this lobbyist’s assigned issues (100)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 1492

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

Original LDA source filings (22)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2026 · first_quarter · Q1

Firm income: —Client expense: $3,510,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

VET

Veterans

Issues related to: - Veterans Administration and Veterans Health Administration procurement and contracting processes for medical technology - VA Program - military/veterans affairs health workforce and talent workforce

HCR

Health Issues

- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions - S.1399 / H.R. 6197, the Health Tech Investment Act, regarding all provisions - H.R. 3521, the Clinical Trial Modernization Act, regarding all provisions - H.R. 3006 / S.1776, the Medicare Beneficiary Co-Pay Fairness Act, regarding all provisions - H.R. 3514, the Improving Seniors Timely Access to Care Act of 2025, regarding all provisions - H.R. 6549, the VA Contracting and Procurement Act, regarding all provisions - H.R. 5509 / S. 2903, Safe Step Act, regarding all provisions - H.R. 5256, 340B ACCESS Act, regarding all provisions - H.R. 7391, Community Health Center Drug Pricing Protection Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B and 340B Rebate Pilot - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - obesity treatments - MFN - Foreign Reference Pricing - CMS Outpatient Prospective Payment System rule - peripheral artery disease (PAD) - PBM and Insurer Reforms

Source: Senate LDA

H.R. 1539

Medical Device Electronic Labeling Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2214

DRUG Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2527

Early Detection of Vision Impairments for Children Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

Show 96 more cited filings

H.R. 3006

To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an ambulatory surgical center.

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3514

Improving Seniors’ Timely Access to Care Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3521

Clinical Trial Modernization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4282

Contact Lens Prescription Verification Modernization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4299

Protecting Patient Access to Cancer and Complex Therapies Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5256

340B ACCESS Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5343

Ensuring Patient Access to Critical Breakthrough Products Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5509

Safe Step Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5526

Biosimilar Red Tape Elimination Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6197

Health Tech Investment Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6549

VA Contracting and Procurement Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 7391

Community Health Center Drug Pricing Protection Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 929

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 946

ORPHAN Cures Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

HRES 1301

Supporting the designation of May 29, 2026, as "Mental Health Awareness in Agriculture Day" to raise awareness around mental health in the agricultural industry and workforce and to continue to reduce stigma associated with mental illness.

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1399

Health Tech Investment Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1717

Ensuring Patient Access to Critical Breakthrough Products Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1776

Medicare Beneficiary Co-Pay Fairness Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1954

Biosimilar Red Tape Elimination Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 266

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2903

Safe Step Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 832

EPIC Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 864

HELP Copays Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1492

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1492

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1492

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1492

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1539

Medical Device Electronic Labeling Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1539

Medical Device Electronic Labeling Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1539

Medical Device Electronic Labeling Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1539

Medical Device Electronic Labeling Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2214

DRUG Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2214

DRUG Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2214

DRUG Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2214

DRUG Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2527

Early Detection of Vision Impairments for Children Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2527

Early Detection of Vision Impairments for Children Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2527

Early Detection of Vision Impairments for Children Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4282

Contact Lens Prescription Verification Modernization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4282

Contact Lens Prescription Verification Modernization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4299

Protecting Patient Access to Cancer and Complex Therapies Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4299

Protecting Patient Access to Cancer and Complex Therapies Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5343

Ensuring Patient Access to Critical Breakthrough Products Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5343

Ensuring Patient Access to Critical Breakthrough Products Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5526

Biosimilar Red Tape Elimination Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5526

Biosimilar Red Tape Elimination Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6167

HEALTH Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 929

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 929

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 946

ORPHAN Cures Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 946

ORPHAN Cures Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 946

ORPHAN Cures Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 946

ORPHAN Cures Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

HRES 1301

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

HRES 1301

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

HRES 1301

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

HRES 1301

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1399

Health Tech Investment Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1717

Ensuring Patient Access to Critical Breakthrough Products Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1717

Ensuring Patient Access to Critical Breakthrough Products Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1954

Biosimilar Red Tape Elimination Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1954

Biosimilar Red Tape Elimination Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1954

Biosimilar Red Tape Elimination Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 266

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 266

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 266

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 266

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 832

EPIC Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 832

EPIC Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 832

EPIC Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 832

EPIC Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 864

HELP Copays Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 864

HELP Copays Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 864

HELP Copays Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 864

HELP Copays Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1352

Increasing Access to Biosimilars Act of 2023

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1352

Increasing Access to Biosimilars Act of 2023

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1352

Increasing Access to Biosimilars Act of 2023

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1352

Increasing Access to Biosimilars Act of 2023

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2748

Contact Lens Prescription Verification Modernization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2748

Contact Lens Prescription Verification Modernization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2748

Contact Lens Prescription Verification Modernization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2748

Contact Lens Prescription Verification Modernization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2940

PASTEUR Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2940

PASTEUR Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2940

PASTEUR Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2940

PASTEUR Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3723

Medical Device Electronic Labeling Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3723

Medical Device Electronic Labeling Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3723

Medical Device Electronic Labeling Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3723

Medical Device Electronic Labeling Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4261

ARC Act of 2023

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4261

ARC Act of 2023

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4261

ARC Act of 2023

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4261

ARC Act of 2023

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5372

Expanding Seniors' Access to Lower Cost Medicines Act of 2023

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2025 · fourth_quarter · Q4

Firm income: —Client expense: $1,510,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

VET

Veterans

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office

Show 18 more original filings

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2025 · first_quarter · Q1

Firm income: —Client expense: $3,340,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. XXXX/ S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, H.R. XXX HELP Copays Act, regarding all provisions - H.R. 2214/ S. XXXX Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day

Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2024 · fourth_quarter · Q4

Firm income: —Client expense: $1,520,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

HCR

Health Issues

- S 1375/HR 830, "HELP Copays Act", regarding all provisions. - PL 117-169, "The Inflation Reduction Act", regarding provisions impacting drug pricing and implementation. - PL 113-5 "Pandemic All Hazards Preparedness Reauthorization", regarding all provisions. - S 1355/HR 2940, "PASTEUR Act", regarding all provisions. - HR 3723, "Medical Device Electronic Labeling Act", regarding all provisions. - HR 2748, "Contact Lens Prescription Verification Modernization Act", regarding all provisions. - HR 4261, "Amputation Reduction and Compassion Act", regarding all provisions. - S 3131/HR 5539, "ORPHAN Cures Act", regarding all provisions. - HR 5372, "Expanding Access to Seniors Access to Lower Cost Medicines Act of 2023", regarding all provisions. - S 2305, "The Biosimilar Red Tape Elimination Act", regarding all provisions. - HR 1352, "Increasing Access to Biosimilars Act of 2023", regarding all provisions. - HR 7174, "Ensuring Pathways to Innovative Cures (EPIC) Act", regarding all provisions - HR 8574, the "340B Affording Care for Communities and Ensuring a Strong Safety-Net (ACCESS) Act", regarding all provisions - HR 7384, "Creating Hope Reauthorization Act", regarding all provisions - HR 7153/ S 3679 the "Dr. Lorna Breen Health Care Provider Protection Reauthorization Act", regarding all provisions Issues related to: - Obesity - Biosimilars - Health equity and diversity in clinical trials - Myopia - Ambulatory surgical services - Access to sterilization capacity for medical technologies - Peripheral artery disease - Cardiovascular health - Stroke care - FDA medical device shortage reporting requirements - Alternative funding programs - PBM practices - Health care workforce wellbeing - Medicaid Drug Rebate Program - the SUSTAIN 340B Act

LBR

Labor Issues/Antitrust/Workplace

- Issues related to diversity, equity and inclusion.

SCI

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2024 · third_quarter · Q3

Firm income: —Client expense: $2,340,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

LBR

Labor Issues/Antitrust/Workplace

- Issues related to diversity, equity and inclusion.

SCI

Science/Technology

Issues related to: - Data privacy - Cybersecurity - Artificial intelligence - Robotics

BUD

Budget/Appropriations

Issues related to: - Contact lens safety, peripheral artery disease, and stroke care, specifically to provisions regarding appropriations report language - Appropriations for Labor Health and Human Services - NIH funding

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2024 · second_quarter · Q2

Firm income: —Client expense: $1,120,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

HCR

Health Issues

- S 1375/HR 830, "HELP Copays Act", regarding all provisions. - PL 117-169, "The Inflation Reduction Act", regarding provisions impacting drug pricing and implementation. - PL 113-5 "Pandemic All Hazards Preparedness Reauthorization", regarding all provisions. - S 1355/HR 2940, "PASTEUR Act", regarding all provisions. - HR 3723, "Medical Device Electronic Labeling Act", regarding all provisions. - HR 2748, "Contact Lens Prescription Verification Modernization Act", regarding all provisions. - HR 4261, "Amputation Reduction and Compassion Act", regarding all provisions. - S 3131/HR 5539, "ORPHAN Cures Act", regarding all provisions. - HR 5372, "Expanding Access to Seniors Access to Lower Cost Medicines Act of 2023", regarding all provisions. - S 2305, "The Biosimilar Red Tape Elimination Act", regarding all provisions. - HR 1352, "Increasing Access to Biosimilars Act of 2023", regarding all provisions. - HR 7174, "Ensuring Pathways to Innovative Cures (EPIC) Act", regarding all provisions - HR 8574, the "340B Affording Care for Communities and Ensuring a Strong Safety-Net (ACCESS) Act", regarding all provisions - HR 7384, "Creating Hope Reauthorization Act", regarding all provisions Issues related to: - Obesity - Biosimilars - Health equity and diversity in clinical trials - Myopia - Ambulatory surgical services - Access to sterilization capacity for medical technologies - Peripheral artery disease - Cardiovascular health - Stroke care - FDA medical device shortage reporting requirements - Alternative funding programs - PBM practices - Health care workforce wellbeing - Medicaid Drug Rebate Program - the SUSTAIN 340B Act

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2024 · first_quarter · Q1

Firm income: —Client expense: $2,730,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

HCR

Health Issues

- S 1375/HR 830, "HELP Copays Act", regarding all provisions. - PL 117-169, "The Inflation Reduction Act", regarding provisions impacting drug pricing and implementation. - PL 113-5 "Pandemic All Hazards Preparedness Reauthorization", regarding all provisions. - S 1355/HR 2940, "PASTEUR Act", regarding all provisions. - HR 3723, "Medical Device Electronic Labeling Act", regarding all provisions. - HR 2748, "Contact Lens Prescription Verification Modernization Act", regarding all provisions. - HR 4261, "Amputation Reduction and Compassion Act", regarding all provisions. - S 3131/HR 5539, "ORPHAN Cures Act", regarding all provisions. - HR 5372, "Expanding Access to Seniors Access to Lower Cost Medicines Act of 2023", regarding all provisions. - S 2305, "The Biosimilar Red Tape Elimination Act", regarding all provisions. - HR 1352, "Increasing Access to Biosimilars Act of 2023", regarding all provisions. Issues related to: - Obesity - Biosimilars - Health equity and diversity in clinical trials - Myopia - Ambulatory surgical services - Access to sterilization capacity for medical technologies - Peripheral artery disease - Cardiovascular health - Stroke care - FDA medical device shortage reporting requirements - Alternative funding programs - 340B - PBM practices - Health care workforce wellbeing - Medicaid Drug Rebate Program

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2023 · fourth_quarter · Q4

Firm income: —Client expense: $1,160,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

HCR

Health Issues

- S 1375/HR 830, "HELP Copays Act", regarding all provisions - PL 117-169, "The Inflation Reduction Act", regarding provisions impacting drug pricing and implementation - PL 113-5 "Pandemic All Hazards Preparedness Reauthorization", regarding all provisions - S 1355/HR 2940, "PASTEUR Act", regarding all provisions - HR 3723, "Medical Device Electronic Labeling Act", regarding all provisions - HR 2748, "Contact Lens Prescription Verification Modernization Act", regarding all provisions - HR 4261, "Amputation Reduction and Compassion Act", regarding all provisions - S 3131/HR 5539, "ORPHAN Cures Act", regarding all provisions - HR 5372, "Expanding Access to Seniors Access to Lower Cost Medicines Act of 2023", regarding all provisions - S 2305, "The Biosimilar Red Tape Elimination Act", regarding all provisions - HR 1352, "Increasing Access to Biosimilars Act of 2023", regarding all provisions Issues related to: - Obesity - Biosimilars - Health equity and diversity in clinical trials - Myopia - Ambulatory surgical services - Access to sterilization capacity for medical technologies - Peripheral artery disease - Cardiovascular health - Stroke care - FDA medical device shortage reporting requirements - Alternative funding programs - 340B - PBM practices - Health care workforce wellbeing - Medicaid Drug Rebate Program

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2023 · third_quarter · Q3

Firm income: —Client expense: $2,350,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

Issues related to: - contact lens safety, peripheral artery disease, and stroke care, specifically to provisions regarding appropriations report language - appropriations for Labor Health and Human Services

HCR

Health Issues

- S 1375/HR 830, "HELP Copays Act", regarding all provisions - PL 117-169, "The Inflation Reduction Act", regarding provisions impacting drug pricing and implementation - PL 113-5 "Pandemic All Hazards Preparedness Reauthorization", regarding all provisions - S 1355/HR 2940, "PASTEUR Act", regarding all provisions - HR 3723, "Medical Device Electronic Labeling Act", regarding all provisions - HR 2748, "Contact Lens Prescription Verification Modernization Act", regarding all provisions - HR 4261, "Amputation Reduction and Compassion Act", regarding all provisions Issues related to: - obesity - biosimilars - health equity and diversity in clinical trials - myopia - ambulatory surgical services - access to sterilization capacity for medical technologies - FDA approval pathways for medical technologies - peripheral artery disease - cardiovascular health - stroke care - FDA medical device shortage reporting requirements - alternative funding programs - 340B - PBM practices - health care workforce wellbeing

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2023 · second_quarter · Q2

Firm income: —Client expense: $850,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

HCR

Health Issues

- S 1375/HR 830, "HELP Copays Act", regarding all provisions - PL 117-169, "The Inflation Reduction Act", regarding provisions impacting drug pricing and implementation - PL 113-5 "Pandemic All Hazards Preparedness Reauthorization", regarding all provisions - S 1355/HR 2940, "PASTEUR Act", regarding all provisions - HR 3723, "Medical Device Electronic Labeling Act", regarding all provisions - HR 2748, "Contact Lens Prescription Verification Modernization Act", regarding all provisions - HR 4261, "Amputation Reduction and Compassion Act", regarding all provisions Issues related to: - obesity - biosimilars - health equity and diversity in clinical trials - myopia - ambulatory surgical services - access to sterilization capacity for medical technologies - FDA approval pathways for medical technologies - peripheral artery disease - cardiovascular health - stroke care - FDA medical device shortage reporting requirements - alternative funding programs - 340B - PBM practices - health care workforce wellbeing

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2023 · first_quarter · Q1

Firm income: —Client expense: $2,490,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

- HR 830, "HELP Copays Act", regarding all provisions - S 652, "Safe Step Act", regarding all provisions - PL 117-169, "The Inflation Reduction Act", regarding provisions impacting drug pricing and implementation - PL 113-5 "Pandemic All Hazards Preparedness Reauthorization", regarding all provisions - PL 115-271, "SUPPORT Act", regarding Section 3204 - PASTEUR Act (2021), regarding all provisions Issues related to: - obesity - biosimilars - health equity and diversity in clinical trials - myopia - ambulatory surgical services - access to sterilization capacity for medical technologies - FDA approval pathways for medical technologies - peripheral artery disease - cardiovascular health - stroke care - FDA medical device shortage reporting requirements - alternative funding programs - 340B - PBM practices - health care workforce wellbeing

BUD

Budget/Appropriations

- Issues related to contact lens safety, peripheral artery disease, and stroke care, specifically to provisions regarding appropriations report language.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2022 · fourth_quarter · Q4

Firm income: —Client expense: $2,270,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

ENV

Environment/Superfund

- HR 4800/S 2546, "Reef Safe Act", regarding all provisions - Issues related to environmental sustainability - Issues related to recycling and plastics - Issues related to coral reefs - Issues related to clean energy - Issues related to carbon tax

HCR

Health Issues

- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, "To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes", regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month, regarding all provisions - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act", regarding all provisions - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "Emergency Use Transparency Act", regarding all provisions - HR 3990/S 2047, "No PFAS in Cosmetics Act", regarding all provisions - HR 8299/S 4386, "To allow for devices with a predetermined change control plan to be marketed without submitting a supplemental application or premarket notification if the changes to such devices are consistent with such plan.", regarding all provisions - HR 7667/S 4348, "Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act", regarding provisions on accelerated approval and diversity in clinical studies - HR 5801, "HELP Copays Act", regarding all provisions - HR 3173/S 3018 - "Improving Seniors Timely Access to Care Act of 2021", regarding all provisions - S 3799 - "PREVENT Pandemics Act", regarding all provisions - HR 3932/S 2076 - "PASTEUR Act of 2021", regarding all provisions - HR 5376 - "Inflation Reduction Act", regarding provisions on drug pricing and provisions related to revenue - HR 7559 - Prescription Information Modernization Act of 2022, regarding all provisions - HR 2617 - "Consolidated Appropriations Act, 2023", regarding provisions related to pharmaceuticals, medical devices, mental health, and tax - Issues related to Dengue - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2022 · third_quarter · Q3

Firm income: —Client expense: $2,170,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

BUD

Budget/Appropriations

- HR 1319, "The American Rescue Plan Act of 2021", regarding all provisions - Issues related to NIH Appropriations (LHHS) - Issues related to HIV/AIDS Ryan White Appropriations (LHHS) and End the Epidemic - Issues related to funding for USAID Appropriations (SFOPS) - Issues pertaining to funding for programs that aim to improve maternal health - Issues pertaining to cross cutting health system strengthening - Issues related to FDA Appropriations - Issues related to contact lenses (FSGG)

ENV

Environment/Superfund

HCR

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2022 · second_quarter · Q2

Firm income: —Client expense: $1,050,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

HCR

Health Issues

- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, "To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes", regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month, regarding all provisions - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act", regarding all provisions - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "Emergency Use Transparency Act", regarding all provisions - HR 5376, "Build Back Better Act", regarding provisions on drug pricing and provisions related to revenue - HR 3990/S 2047, "No PFAS in Cosmetics Act", regarding all provisions - HR 8299/S 4386, FDA review of certain changes to software in medical devices or predetermined change control plans - HR 7667/S 4348, "Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act", regarding provisions on accelerated approval and diversity in clinical studies - HR 5801, "HELP Copays Act", regarding all provisions - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2022 · first_quarter · Q1

Firm income: —Client expense: $2,320,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, legislation to expand access to adult vaccines under Medicare Part B, regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act" - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, the Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "The Emergency Use Transparency Act", regarding all provisions - HR 5376, "Build Back Better Act", regarding provisions on drug pricing and provisions related to revenue - HR 3990/S 2047, No PFAS in Cosmetics Act - HR 2467, PFAS Action Act of 2021 - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation - Issues related to FDA review of certain changes to software in medical devices or predetermined change control plans - Issues related to HR ___, "Medical Device User Fee Amendments of 2022"

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2021 · fourth_quarter · Q4

Firm income: —Client expense: $880,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - Issues related to prescription drug pricing - Issues pertaining to Medicare coverage of vaccines - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - HR 446, Expressing support for the goals and ideals of National Stroke Awareness Month - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act" - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, the Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - Issues related to clinical research diversity - S 3394, "The Emergency Use Transparency Act", regarding all provisions - HR 5376, "Build Back Better Act", regarding all provisions

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2021 · third_quarter · Q3

Firm income: —Client expense: $1,920,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - Issues related to prescription drug pricing - Issues pertaining to Medicare coverage of vaccines - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - HR 446, Expressing support for the goals and ideals of National Stroke Awareness Month - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act" - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, the Contact Lens Prescription Verification Modernization Act - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act - Issues related to clinical research diversity

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2021 · second_quarter · Q2

Firm income: —Client expense: $800,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to contact lens safety - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - HR 446, Expressing support for the goals and ideals of National Stroke Awareness Month - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act" - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2021 · first_quarter · Q1

Firm income: —Client expense: $2,480,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2020 · fourth_quarter · Q4

Firm income: —Client expense: $1,450,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

- H.R. 863 - DXM Abuse Prevention Act of 2019, regarding all provisions - S. 726 - Personal Care Products Safety Act, regarding all provisions - Issues related to the regulation of over-the-counter drugs - Issues related to cosmetic regulatory reform - Issues related to cosmetic animal testing - Issues related to biosimilars - Issues related to maternal mortality - Issues related to contact lens safety - Issues related to medical product communications - Issues related to medical product review - Issues related to ingredient safety - Issues related to diversity in clinical trials - Issues related to health care pricing transparency - Issues related to peripheral artery disease - H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - Issues related to drug importation - S. 2543, "Prescription Drug Pricing Reduction Act of 2019", regarding all provisions - H.R. 19, "Lower Costs, More Cures Act of 2019", regarding all provisions - H.R. 748/ S. 3458, "'Coronavirus Aid, Relief, and. Economic Security Act'', regarding all provisions - H.R. 6074, "Coronavirus Preparedness and Response Supplemental Appropriations Act", regarding all provisions - H.R. 6201, "Families First Coronavirus Response Act", regarding all provisions - H.R. 3975, the Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 5663, the Safeguarding Therapeutics Act, regarding all provisions - Issues related to counterfeit health care goods - S. 3468, Preventing Essential Medical Device Shortages Act of 2020 - Issues related to counterfeit medical devices and combination products and authority to destroy counterfeit medical products - Issues related to reporting medical device shortages - Issues related to pandemic response - S. 2740, "Over the Counter Monograph Safety, Innovation, and Reform Act of 2019", regarding all provisions - H.R. 5279, "Cosmetic Safety Enhancement Act", regarding all provisions - H.R. 4296, "Safe Cosmetics and Personal Care Products Act of 2019", regarding all provisions - Issues related to social determinants of health - H.R. 5076/S. 1872, "Protecting Seniors Through Immunization", regarding all provisions - H.R.6062, "To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes", regarding all provisions. - H.R.6952, "To direct the President to appoint a Medical Supplies Response Coordinator to coordinate the efforts of the Federal Government regarding the supply and distribution of certain supplies and equipment relating to COVID-19", regarding all provisions - S.3942, "Securing America's Medical Supply Chain and Advancing the Production of Life Saving Medicines Act", regarding all provisions - S.3945, "Bring Entrepreneurial Advancements To Consumers Here In North America Act", regarding all provisions - S.3780, "HOME Act", regarding all provisions - S.3781, "PART Act", regarding all provisions - Issues related to diversity in clinical trials - Issues related to 340B - S.4613, The Contact Lens Rule Modernization Act, regarding all provisions - H.R.3107, "Improving Seniors Timely Access to Care Act of 2019, regarding all provisions - Executive Order 13948: Lowering Drug Prices by Putting America First - Executive Order 13939: Lowering Prices for Patients by Eliminating Kickbacks to Middlemen - Executive Order 13938: Increasing Drug Importation To Lower Prices for American Patients - Executive Order 13937: Access to Affordable Life-Saving Medications -H.R.133 - Consolidated Appropriations Act, 2021, including legislation regarding average sales price (ASP) reporting requirements for certain hyaluronic acid (HA) products that are classified as devices, but reimbursed as drugs under Medicare Part B

- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, "To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes", regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month, regarding all provisions - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act", regarding all provisions - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "Emergency Use Transparency Act", regarding all provisions - HR 5376, "Build Back Better Act", regarding provisions on drug pricing and provisions related to revenue - HR 3990/S 2047, "No PFAS in Cosmetics Act", regarding all provisions - HR 8299/S 4386, FDA review of certain changes to software in medical devices or predetermined change control plans - HR 7667/S 4348, "Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act", regarding provisions on accelerated approval and diversity in clinical studies - HR 5801, "HELP Copays Act", regarding all provisions - HR 3173/S 3018 - "Improving Seniors Timely Access to Care Act of 2021" - S 3799 - "PREVENT Pandemics Preparedness Act" - HR 3932/S 2079 - "PASTEUR Act of 2021" - HR 5376 - "Inflation Reduction Act", regarding provisions on prescription drugs - Issues related to Dengue - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation